AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 284: F1105-F1114, 2003; doi:10.1152/ajprenal.00328.2002
0363-6127/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, H.
Right arrow Articles by Neumayer, H.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, H.
Right arrow Articles by Neumayer, H.-H.
Vol. 284, Issue 5, F1105-F1114, May 2003

Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis

Harm Peters1, Sebastian Martini1, Raiko Woydt1, Matthias Rückert1, Fuijo Shimizu2, Hiroshi Kawachi2, Lutz Liefeldt1, Stephanie Krämer1, and Hans-H. Neumayer1

1 Division of Nephrology, Charité, Campus Mitte, Humboldt-University, D-10098 Berlin, Germany; and 2 Department of Cell Biology and Institute of Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan

Moderate alcohol consumption has shown beneficial effects in experimental and human cardiovascular disease. With the use of rat models of acute and chronic progressive anti-thy1 glomerulonephritis (GN), we tested the hypothesis that moderate alcohol intake is protective in renal fibrotic disease. In acute anti-thy1 GN, untreated nephritic rats showed marked mesangial cell lysis and induced nitric oxide production at day 1 and high proteinuria, glomerular matrix accumulation, and transforming growth factor (TGF)-beta 1, fibronectin, and plasminogen activator inhibitor (PAI)-1 expression at day 7 after disease induction, respectively. In animals 15 wk after induction of chronic progressive anti-thy1 GN, disease was characterized by significantly reduced renal function, persisting albuminuria as well as increased glomerular and tubulointerstitial matrix expansion, TGF-beta 1, fibronectin, and PAI-1 protein expression. In both anti-thy1 GN models, an ethanol intake of ~2 ml per day and animal was achieved, however, disease severity was not significantly altered by moderate alcohol consumption in any of the protocols. In conclusion, moderate alcohol intake does not influence renal matrix protein production and accumulation in acute and chronic progressive anti-thy1 glomerulofibrosis. The study suggests that, in contrast to cardiovascular disorders, moderate alcohol consumption might not provide specific protection in renal fibrotic disease.

fibrosis; transforming growth factor-beta ; inducible nitric oxide production; beer


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Martini, S. Kramer, T. Loof, Y. Wang-Rosenke, U. Daig, K. Budde, H.-H. Neumayer, and H. Peters
S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1761 - F1770.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Y. Wang, S. Kramer, T. Loof, S. Martini, S. Kron, H. Kawachi, F. Shimizu, H.-H. Neumayer, and H. Peters
Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F167 - F176.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Kramer, T. Loof, S. Martini, M. Ruckert, Y. Wang, T. Bohler, F. Shimizu, H. Kawachi, H.-H. Neumayer, and H. Peters
Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F359 - F368.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online